Organon & Co

OGN

Company Profile

  • Business description

    Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women’s health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

  • Contact

    30 Hudson Street
    Floor 33
    Jersey CityNJ07302
    USA

    T: +1 551 430-6900

    https://www.organon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    10,000

Stocks News & Analysis

stocks

Microsoft earnings: Strength in cloud, guidance mixed

We think investors should be on board when Azure accelerates in the third quarter.
stocks

Chart of the week: Small caps lagging

This week's chart of the week comes from Morningstar's Market Strategist's take on small caps
stocks

An impending merger just raised our fair value for this ASX retail giant

The deal is set to deliver enhanced scale, cost savings and new synergies.  

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,422.1017.40-0.21%
CAC 407,350.3777.99-1.05%
DAX 4019,077.54179.80-0.93%
Dow JONES (US)41,763.46378.08-0.90%
FTSE 1008,110.1049.53-0.61%
HKSE20,317.3363.31-0.31%
NASDAQ18,095.15512.78-2.76%
Nikkei 22539,081.25196.14-0.50%
NZX 50 Index12,580.8058.10-0.46%
S&P 5005,705.45108.22-1.86%
S&P/ASX 2008,160.0020.40-0.25%
SSE Composite Index3,279.8213.590.42%

Market Movers